EXOS
Exos is a human performance company providing coaching and technology, with services like employee well-being programs and athlete training.
Secondary Market Price
How EXOS Measures Up
To help you manage your EXOS equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of EXOS's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future EXOS Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for EXOS's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Exos is a human performance company that provides coaching and related solutions to businesses, athletes, and practitioners. Its current operations involve developing and managing holistic employee well-being programs, operating corporate fitness centers, and offering consulting to build high-performance cultures within organizations. For athletes, the company delivers training, physical therapy, and rehabilitation services across professional, collegiate, and youth levels. With a history spanning nearly 30 years, Exos has evolved from its initial coaching focus to also include performance space design, virtual coaching via the Exos App, and educational programs for practitioners. The company serves a client base that includes over 20% of Fortune 100 companies.
A recent major development for Exos is its acquisition of the sports technology company Infinite Athlete and its subsidiary, Biocore. This strategic move signals the company's future direction, which centers on combining data analytics and technology with its established human coaching expertise. The acquisition supports the company's stated mission to enhance performance and safety across sports and work, suggesting a continued expansion into data-driven performance solutions.
- Polaris Partners
- ABS Capital Partners
- Madrone Capital Partners
- BDT & MSD Partners
- Founder, Founder Mark Verstegen
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is EXOS worth joining?
Deciding whether to join any startup like EXOS requires a careful evaluation of the company's potential, your role, and the overall compensation package. Tools like Prospect can help you understand the potential future value of your equity compensation, which is a critical part of the decision.
What should I do with my EXOS stock?
The right strategy for your EXOS stock depends on your personal financial goals, risk tolerance, and the terms of your equity grant. Platforms like Prospect provide personalized models and tax-optimized strategies to help you decide whether to exercise, sell, or hold your shares to maximize their value.
Can you sell EXOS stock?
Selling stock in a private company like EXOS is often possible through secondary markets or company-approved tender offers, though there may be restrictions. Prospect offers tools to help you navigate these transactions, determine how much to sell, and identify which shares are the most tax-optimal to part with.
How can I find the value of my EXOS stock?
Determining the value of private stock can be difficult, as it isn't publicly traded and fluctuates based on company performance and funding rounds. Prospect uses predictive models trained on venture capital data to help you forecast your equity's potential future value and model different scenarios.
What is EXOS's equity worth?
The exact worth of EXOS's equity is not public information and depends on factors like the company's most recent 409A valuation and private market demand. You can get a clearer picture of your personal stake's potential by using equity management platforms that provide future price projections and scenario analysis.
What is EXOS's stock ticker symbol?
As a private, pre-IPO company, EXOS does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they become publicly traded on a stock exchange like the NYSE or NASDAQ.
Can I buy or sell EXOS stock?
Opportunities to buy or sell stock in a private company like EXOS are typically limited to employees exercising options or participating in tender offers and secondary market sales. Prospect provides tax-optimized strategies for exercising options and tools to help you decide when and how much to sell for the best outcome.
What is the criteria to buy or invest in EXOS stock?
Investing in a private startup like EXOS is generally restricted to accredited investors, venture capital firms, or employees who receive equity as part of their compensation. If you are an employee, you can typically "buy" stock by exercising your stock options according to the schedule in your grant agreement.
